GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Chenguang Biotech Group Co Ltd (SZSE:300138) » Definitions » ROC (Joel Greenblatt) %

Chenguang Biotech Group Co (SZSE:300138) ROC (Joel Greenblatt) % : 4.99% (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Chenguang Biotech Group Co ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Chenguang Biotech Group Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 4.99%.

The historical rank and industry rank for Chenguang Biotech Group Co's ROC (Joel Greenblatt) % or its related term are showing as below:

SZSE:300138' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 3.74   Med: 9.2   Max: 13.09
Current: 4.16

During the past 13 years, Chenguang Biotech Group Co's highest ROC (Joel Greenblatt) % was 13.09%. The lowest was 3.74%. And the median was 9.20%.

SZSE:300138's ROC (Joel Greenblatt) % is ranked worse than
71.34% of 1905 companies
in the Consumer Packaged Goods industry
Industry Median: 12.06 vs SZSE:300138: 4.16

Chenguang Biotech Group Co's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -12.40% per year.


Chenguang Biotech Group Co ROC (Joel Greenblatt) % Historical Data

The historical data trend for Chenguang Biotech Group Co's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chenguang Biotech Group Co ROC (Joel Greenblatt) % Chart

Chenguang Biotech Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.01 11.85 13.09 12.21 3.74

Chenguang Biotech Group Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.49 5.21 7.84 -1.86 4.99

Competitive Comparison of Chenguang Biotech Group Co's ROC (Joel Greenblatt) %

For the Farm Products subindustry, Chenguang Biotech Group Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chenguang Biotech Group Co's ROC (Joel Greenblatt) % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Chenguang Biotech Group Co's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Chenguang Biotech Group Co's ROC (Joel Greenblatt) % falls into.


;
;

Chenguang Biotech Group Co ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(438.932 + 1720.145 + 808.274) - (264.513 + 0 + 149.023)
=2553.815

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(449.114 + 3862.446 + 668.037) - (376.855 + 0 + 360.052)
=4242.69

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Chenguang Biotech Group Co for the quarter that ended in Dec. 2024 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2024  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=252.708/( ( (1674.629 + max(2553.815, 0)) + (1662.56 + max(4242.69, 0)) )/ 2 )
=252.708/( ( 4228.444 + 5905.25 )/ 2 )
=252.708/5066.847
=4.99 %

Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chenguang Biotech Group Co  (SZSE:300138) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Chenguang Biotech Group Co ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Chenguang Biotech Group Co's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Chenguang Biotech Group Co Business Description

Traded in Other Exchanges
N/A
Address
Number 1 Chenguang Road, Hebei Province, Quzhou, CHN, 057250
Chenguang Biotech Group Co Ltd is engaged in the processing of agricultural products and herb extracts in China. Its products include natural colors, including paprika oleoresin, marigold oleoresin, curcumin, red rice red, red cabbage, and red beet; and natural spice extracts and essential oils, such as capsicum oleoresin, zanthoxylum oil and oleoresin, black pepper oil and oleoresin, ginger oil and oleoresin, turmeric oil, star anise oil and oleoresin, cumin oil and oleoresin, garlic oil and oleoresin, and common fennel oil and oleoresin.
Executives
Li Feng Fei Executives
Zhou Jing Directors, Directors, and Executives
Li Yue Zhai Director
Lian Yun He Executives
Chen Yun Xia Executives
Zhao Tao Supervisors
Yuan Xin Ying Supervisors
Liu Zhang Lin Independent director
Lu Qing Guo Directors, executives
Zhou Fang Sheng Independent director
Wang Shu Hong Independent director
Liu Ying Shan Director
Han Wen Jie Executives
Liu Dong Ming Supervisors
Yang Wen Fang Supervisors

Chenguang Biotech Group Co Headlines

No Headlines